Bladder-sparing strategies for transitional cell carcinoma (Q34053109)

30 July 2017

1 reference

title

Bladder-sparing strategies for transitional cell carcinoma (English)

1 reference

30 July 2017

Feneley MR

1

1 reference

30 July 2017

Schoenberg M

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

56

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

549-560

1 reference

Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Conservative management of muscle-infiltrating bladder cancer: prospective experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

The value of a second transurethral resection in evaluating patients with bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Invasive, high grade transitional cell carcinoma of the bladder treated with transurethral resection. A survival analysis focusing on TUR as monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Treatment of invasive bladder cancer by local resection and high dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

A clinicopathologic evaluation of partial cystectomy for carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Partial cystectomy for invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Segmental Resection in the Management of Bladder Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Survival after curative treatment of muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Morbidity after preoperative radiotherapy and cystectomy in patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Selective bladder preservation by combination treatment of invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Neoadjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) chemotherapy and bladder preservation for muscle-infiltrating transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Organ-sparing treatment of advanced bladder cancer: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Comparison of transurethral resection to radical therapies for stage B bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

The current status of transurethral resection in the diagnosis and therapy of carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Control of Bladder Tumors by Endoscopic Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Conservative management of stage T2 or T3a bladder cancer with deep transurethral resection followed by four cycles of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Is bladder conservation feasible? An Indian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Conservative management of advanced bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Combined treatment of invasive bladder carcinoma with transurethral resection, induction chemotherapy, and radical radiotherapy plus concomitant protracted infusion of cisplatin and 5-fluorouracil: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Alternating chemo-radiotherapy in bladder cancer: A conservative approach

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

A pilot study of chemotherapy alternating with twice-a-day accelerated radiation therapy as an alternative to cystectomy in muscle infiltrating (stages T2 and T3) cancer of the bladder: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

Segmental Resection for Carcinoma of the Bladder: Review of 102 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900714-7

7 January 2021

10.1016/S0090-4295(00)00714-7

Identifiers

DOI

1 reference

30 July 2017

1 reference